Russian Journal of AllergyRussian Journal of AllergyРоссийский Аллергологический Журнал1810-88302686-682XPublishing House ABV Press101710.36691/RJA1017ArticlesСтатьиTreatment of nasal polyposis. Mometasone furoate. ReviewЛечение полипозного риносинусита. Мометазона фуроат. Обзор литературыKochetkovP AКочетковП А

Клиника болезней уха, горла и носа; Московская медицинская академия им. И.М. Сеченова

LopatinAndrey StanislavovichЛопатинАндрей Станиславович

Клиника болезней уха, горла и носа; Московская медицинская академия им. И.М. Сеченова

lopatin@lor.ruKochetkovP ALopatinA SМосковская медицинская академия им. И.М. Сеченова1508200964NO4 (2009)№4 (2009)31110032020Copyright ©; 2009, Pharmarus Print MediaCopyright ©; 2009, Фармарус Принт Медиа2009Pharmarus Print MediaФармарус Принт Медиаhttps://rusalljournal.ru/raj/article/view/1017

This publication is devoted to review of safety and efficacy of mometasone furoate for treatment of nasal polyposis. Authors present the results of last researches of this topic with high level of evidence. In the article authors review the following questions: system biovialability, using mometasone furoate as monotherapy and after surgery for treating nasal polyposis. Adverse events, safety and the reasons of unsuccessful treating were resumed.

Публикация посвящена обзору эффективности и безопасности применения мометазона фуроата при полипозном синусите по данным литературных источников. Приведены результаты последних исследований с высоким уровнем доказательности. Рассмотрены вопросы системной биодоступности, применения топических стероидов в качестве монотерапии и в послеоперационном периоде. Дана оценка безопасности применения мометазона фуроата и оценены его возможные побочные эффекты и возможные причины неэффективности лечения.

nasal polyposismometasone furoatetopical steroid therapyполипозный синуситтопические стероидымометазона фуроатЛанцов А.А., Рязанцев С.В., Цецарский Б.М. и соавт. Эпидемиология полипозных риносинуситов. СПб., 1999, c. 6-17.Stolbova D. Dedicna slozka v etiologii nosnich polypu. Cs. otolaryngol. 1982, v. 15, p. 211-217.Johanson L., Akerhund A., Holmberg K. Prevalrnce of nasal polyps in adults: the skove population-based study. 3-rd International Consensus Conference on Nasal Polyposis. Abstracts book. 2004, p. 1-2.Gordts F., Clement P. Prevalence of sinusitis and polyposis in non-ENT population. 3-rd International consensus conference on nasal polyposis. Abstracts book. 2004, p. 1.Larsen P., Tos M. Origination and frequency of nasal polyps based on 150 consecutive autopsies. 3-rd International Consensus Conference on Nasal Polyposis. Abstracts book. 2004, p. 2.Bascom R., Wachs M., Nacterio R.M. et al. Basophil influx occurs after nasal antigen challenge: Effects of topical corticosteroid pretreatment. Allergy Clin. Immunol. 1988, v. 81, p. 580-589.Berkowitz R.B., Bernstein D.I., LaForce C. et al. Onset of action of mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis. Allergy. 1999, v. 54, p. 64-69.Ruhno J., Howie K., Anderson M. et al. The increased numbers of epithelial mast cells in nasal polyps and adjacent turbinates is not allergy-dependent. Allergy. 1990, v. 45, p. 370-474Slovick F.T., Abboud C.N., Brennan J.K. et al. Modulation of in vitro eosinophil progenitors by hydro-cortisone: Role of accessory cells and interleukins. Blood. 1985, v. 66, p. 1072-1079.Badia L., Lund V. Topical corticosteroids in nasal polyposis. Drugs. 2001, v. 61, p. 573-578.Benninger M.S., Ahmad N., Marple B.F. The safety of intra-nasal steroids. Otolaryngol. Head Neck Surg. 2003, v. 129, № 6, p.739-750.Nasonex® Nasal Spray Product Information sheet. Schering Corporation. Kenilworth, NJ. Product information Nasonex (2005). www.spfiles.com/ <http://www.spfiles.com/>pinasonex.pdfDaley-Yates P.T., Kunka R.L., Yin Y. et al Biovailability of fluticasone priopionate and mometasone furoate aqueos nasal sprays. Eur. J. Clin. Pharmacol. 2004, v. 60, p. 265-268.Derendorf H., Daley-Yates P.T., Pierre L.N. et al. Bioavalability and metabolism of mometasone furoate: pharmacology versus methodology. J. Clin. Pharmacol. 2002, v. 42, p. 383-387.Coren J. Intranasal corticosteroids for allergic rhinitis: how to different agent compare. Allergy Clin. Immunol., 1999, v. 104, p. 144-149Issar M., Sahasranaman S., Buchwald P. et al. Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids. Eur. Respir. J. 2006, v. l 27, p. 511-516.Brannan M.D., Seiberling V., Cutler D.L. et al. Lack of systemic activity with intranasal mometasone furoate. Ann. Allergy, Asthma Immunol. 1997, v. 97, p. 198.Brannan M.D. et al. J. Allergy Clin. Immunol. 1996. v. 97, p. 198. Abstract 62.Boner A.L. Effect of intranasal corticosteroids on the hypothalamic-pituatary adrenal axis in children. J. Allergy. Clin. Immunol. 2001, v. 108, p. 32-39.Szefler S.J. Pharmacokinetics of intranasal corticosteroids. J. Allergy Clin. Immunol. 2001, Suppl., 1.v. 108, p. 26-23.Schenkel E.J., Skoner D.P., Bronsky E.A. et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics. 2000, v. 105, p. 22.Glenis Scadding Optimal Management of Nasal Congestion Caused by Allergic Rhinitis in Children. Safety and Efficacy of Medical Treatments. Review Article. Pediatr. Drugs. 2008, p. 161-162.Brannan M.D., Herron J.M., Affrime M.B. Safety and tolerability of once-daily mometasone furoate nasal aqueous spray in children. Clin. Ther. 1997, v. 19, p. 1330-1339.Baroody F.M., Cheng C., Moylan B. et al. Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. Otola-ryngol. Head Neck Surg. 2001, v. 127, No. 2, p. 193-199.Minshall E., Ghaffar O., Cameron L. et al. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol. Head Neck Surg. 1998, v. 118, p. 648-654.Allen D.B. Systemic affects of intranasal steroids: an endocrinologist`s perspective. Allergy Clin. Immunol. 2000, v. 106, p. 179-190.Pedersen C.B., Mygind N., Sprensen H. et al. Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol. Clinical results. Acta Otolaryngol. 1972, v. 92, p. 256-259Meltzer et al. J. Allergy Clin. Immunol. 2000, v. 106, p. 630.Nayak et al. Ann. Asthma Allergy Immunol. 2002, v. 89, p. 271.Small C.B., Hernandes J., Reyes A. et al. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J. Allergy Clin. Immunol. 2005, v. 116, p. 1275-1281.Stjarne P., Blomgren K., Caye-Tomasen P. et al. The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study. Acta otolaryngol. 2006, v. 126, p. 606-612.Stjarne P., Mosges R., Jorissen M. et al. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. Arch. Otolaryngol. Head Neck Surg. 2006, v. 132, p. 179-185.Schenkel E. Features of mometasone furoate nasal spray and its utility in the management of allergic rhinitis. Expert Opin. Pharmacother. 2003, v. 4, p. 1579-1591.Meltzer E.O., Bachert C., Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin and placebo. J. Allergy. Clin. Immunol. 2005, v. 116, p. 1289-1295.Nielsen L.P., Myging N, Dahl R. Intranasal corticosteroids for allergic rhinitis: superior relief? Drugs. 2001, v. 61, p. 1563-1579.Bloom M., Staudinger H., Schering-Plough Research Institute, Kenilworth, NJ, and the nasal polyposis team. Abstract, No 279. 2003.Bloom M., Staudinger H. Effect of mometasone furoate nasal spray on nasal polyposis. Poster. Amsterdam, The Netherlands: EAACI, 2004.Лопатин А.С., Сидоренко И.В., Захаржевская Т.В и соавт. Эффективность Назонекса в лечении аллергического ринита и хронического полипозного риносинусита. Вестн. оториноларингологии. 2000, № 4, с. 60-63.Jankowski R., Schrewelius C., Bonfils P. еt al. Efficacy and toleralability of budesonide aqueous nasal spray treatment in patients with nasal polyps. Arch.Otolaryngol. Head Neck Surg. 2001, v. 127, p. 447-452.Dijkstra M. D., Ebbensw F. A., Poublon R. M. еt al. Fluticasone propionate aqueous nasal spray does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps 1 year after functional endoscopic sinus surgery. Clin. Exp. Allergy. 2004, v. 34, p. 1395-1400.Rowe-Jones J.M., Medcalf M., Durham S.R. et al. Functional Endoscopic Sinus Surgery: 5 year follow up and results of a prospective, randomized, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray. Rhinology. 2005, v. 43, p. 2-10.Stjarne P., Olsson P. Efficacy of Mometasone Furoate Nasal Spray in the Postsurgical Treatment of Nasal Polyposis. 2006. Schering-Plough Research Institute. Abstract, No 1361.Slavin R.G. Medical management of nasal polyps and sinusitis. J. Allergy Clin. Immunol. 1991, v. 88, p. 141-146.